These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1247198)

  • 41. Experimental bovine infectious keratoconjunctivitis caused by sunlamp irradiation and Moraxella bovis infection: resistance to re-exposure with homologous and heterologous Moraxella bovis.
    Hughes DE; Pugh GW; McDonald TJ
    Am J Vet Res; 1968 Apr; 29(4):829-33. PubMed ID: 5642356
    [No Abstract]   [Full Text] [Related]  

  • 42. Detection of Moraxella bovis antibodies in the SIgA, IgG, and IgM classes of immunoglobulin in bovine lacrimal secretions by an indirect fluorescent antibody test.
    Killinger AH; Weisiger RM; Helper LC; Mansfield ME
    Am J Vet Res; 1978 Jun; 39(6):931-4. PubMed ID: 352205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Wavelength of ultraviolet radiation that enhances onset of clinical infectious bovine keratoconjunctivitis.
    Kopecky KE; Pugh GW; Hughes DE
    Am J Vet Res; 1980 Sep; 41(9):1412-5. PubMed ID: 7447134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis.
    Lepper AW; Moore LJ; Atwell JL; Tennent JM
    Vet Microbiol; 1992 Sep; 32(2):177-87. PubMed ID: 1359693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experimentally induced bovine infectious keratoconjunctivitis: effectiveness of intramuscular vaccination with viable Moraxella bovis culture.
    Hughes DE; Pugh GW
    Am J Vet Res; 1971 Jun; 32(6):879-86. PubMed ID: 4997447
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhancement of infectious bovine keratoconjunctivitis by modified-live infectious bovine rhinotracheitis virus vaccine.
    George LW; Ardans A; Mihalyi J; Guerra MR
    Am J Vet Res; 1988 Nov; 49(11):1800-6. PubMed ID: 2854704
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a laboratory animal model for infectious bovine keratoconjunctivitis.
    Chandler RL; Turfrey BA; Smith K
    Res Vet Sci; 1982 Jan; 32(1):128-30. PubMed ID: 7045996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccination of cattle against pseudorabies (Aujeszky's disease) with homologous virus (herpes suis) and heterologous virus (herpes bovis 1).
    Biront P; Vandeputte J; Pensaert MB; Leunen J
    Am J Vet Res; 1982 May; 43(5):760-3. PubMed ID: 6283963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK).
    Lepper AW; Atwell JL; Lehrbach PR; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1995 Jul; 45(2-3):129-38. PubMed ID: 7571364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of tulathromycin for treatment of cattle with acute ocular Moraxella bovis infections.
    Lane VM; George LW; Cleaver DM
    J Am Vet Med Assoc; 2006 Aug; 229(4):557-61. PubMed ID: 16910856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infectious bovine keratoconjunctivitis: comparison of a fluorescent antibody technique and cultural isolation for the detection of Moraxella bovis in eye secretions.
    Pugh GW; Hughes DE; Kohlmeier RH; Wallace JR; Graham CK
    Am J Vet Res; 1977 Sep; 38(9):1349-52. PubMed ID: 335929
    [No Abstract]   [Full Text] [Related]  

  • 52. Infectious bovine keratoconjunctivitis I. Experimental production.
    Nayar PS; Saunders JR
    Can J Comp Med; 1975 Jan; 39(1):22-31. PubMed ID: 163126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemagglutination, autoagglutination and pathogenicity of Moraxella bovis strains.
    Gil-Turnes C
    Can J Comp Med; 1983 Oct; 47(4):503-4. PubMed ID: 6667436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infectious bovine keratoconjunctivitis: bacteriologic, immunologic, and clinical responses of cattle to experimental exposure with Moraxella bovis.
    Weech GM; Renshaw HW
    Comp Immunol Microbiol Infect Dis; 1983; 6(1):81-94. PubMed ID: 6825419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of bovine carriers of Moraxella bovis by comparative cultural examinations of ocular and nasal secretions.
    Pugh GW; McDonald TJ
    Am J Vet Res; 1986 Nov; 47(11):2343-5. PubMed ID: 3789493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of acute ocular Moraxella bovis infections in calves with a parenterally administered long-acting oxytetracycline formulation.
    Smith JA; George LW
    Am J Vet Res; 1985 Apr; 46(4):804-7. PubMed ID: 4014830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infectious bovine keratoconjunctivitis: treatment of Moraxella bovis infections with antibiotics.
    Pugh GW; McDonald TJ
    Proc Annu Meet U S Anim Health Assoc; 1977; (81):120-30. PubMed ID: 286339
    [No Abstract]   [Full Text] [Related]  

  • 58. Neural changes in vaccinated calves challenge exposed with virulent infectious bovine rhinotracheitis virus.
    Narita M; Inui S; Nanba K; Shimizu Y
    Am J Vet Res; 1980 Dec; 41(12):1995-9. PubMed ID: 6259976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
    Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
    Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors related to the prevalence of infectious bovine keratoconjunctivitis.
    Webber JJ; Selby LA
    J Am Vet Med Assoc; 1981 Oct; 179(8):823-6. PubMed ID: 6281222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.